Director Market Access

Merck Gruppe - MSD Sharp & Dohme; Pennsylvania; On-site; USD 170,000 - 260,000; Full time

Job summary

Merck Gruppe - MSD Sharp & Dohme seeks a Director, Global Market Access to lead the global access strategy for a newly acquired antiviral asset with potential first-in-class and long-acting properties. The role focuses on payer value, evidence planning, and stakeholder engagement to enable broad, sustainable access.

The position requires developing payer materials, coordinating with regional teams, and guiding economic models and budget impact analyses across the portfolio.

Qualifications

• Bachelor’s degree is required.
• MBA or advanced degree is preferred.
• 8+ years in pharmaceutical market access, pricing/reimbursement, marketing or health economics.
• Global strategic mindset with strong understanding of access and reimbursement.

Responsibilities

• Develop global payer value proposition and access strategy.
• Generate data-driven insights on policy developments, HTA/NITAG insights, and payer trends.
• Drive alignment between access and clinical, commercial, and evidence plans.
• Manage access performance reviews, forecasts, and risk/opportunity assessments.
• Lead development of payer value decks, access tools, and training for global and regional teams.
• Coordinate cross-functional partnerships to guide development of economic models and budget impact analyses.
• Support capability-building across regions with strategic guidance and issue escalation on complex access challenges.

Skills

Global Market Access

Pricing & Reimbursement

Marketing

Health Economics

Global Strategy

Education

Bachelor’s degree

MBA or advanced degree

Job description

Job Description

Our Global Market Access (GMAx) organization is dedicated to delivering breakthrough innovations that extend and improve the lives of individuals worldwide. Our focus is on innovation and launch execution excellence, translating scientific advancements into impactful medicines that help people globally. This role presents an exciting opportunity to advance patient access and has a significant impact on our growing vaccines & infectious diseases portfolio.

The Director, Global Market Access will lead the global access strategy for our company's new acquisition of a potentially first-in-class, long-acting, strain-agnostic antiviral designed to prevent influenza in individuals at higher risk of complications. This acquisition expands and complements our respiratory portfolio and pipeline and is currently in Phase 3 of clinical development. Influenza continues to pose a significant global health threat, causing widespread illness, morbidity and death each year especially in older adults and immunocompromised individuals, such as those with cancer and chronic diseases. The asset offers substantial opportunities to reduce burden of influenza-related complications in high-risk individuals and requires comprehensive go‑to‑market and segmentation strategy, value proposition, and stakeholder engagement plan to optimize patient access globally.

The Director, Global Market Access is responsible for development of the global market access strategy including the identification and shaping of access risks, opportunities, and long‑term planning. This includes developing payer value resources, and influencing evidence plans to enable timely, broad, and sustainable access for this newly acquired asset. Reporting to the Executive Director, Global Vaccines Access and Pricing Lead, the Director is responsible for driving alignment across global, regional, and country GMAx teams and coordinating with Marketing, OR/CORE, Medical Affairs, Policy, Finance.

Key Responsibilities

• Lead development and integration of global payer value proposition, global access strategy and negotiation strategies
• Generate and interpret data‑driven insights, including competitive landscape, policy developments, payer and HTA/NITAG insights, and payer environment trends.
• Drive alignment across the portfolio, linking access strategy with clinical, commercial, and evidence development planning.
• Manage access performance reviews, forecasts, and risk/opportunity assessments and ensure alignment between access needs and evidence investment decisions
• Lead development of payer value decks, access tools, and internal training for global and regional teams.
• Coordinate cross‑functional partnerships (Marketing, OR/CORE, Medical Affairs, Policy, Finance) to guide development of economic models, budget impact analyses, real‑world evidence plans, and value narratives.
• Support capability‑building across regions by providing strategic guidance, coaching, and issue escalation support on complex access challenges.

Education

• Required: Bachelor’s degree
• Preferred: MBA or advanced degree

Experience and Skills

• Minimum 8+ years in pharmaceutical market access, pricing/reimbursement, marketing or health economics.
• Global strategic mindset with strong understanding of access and reimbursement